Navigation Links
Cholesterol Drug Also Beneficial for Patients With Diabetes

A new study shows patients with type 2 diabetes could benefit from statins to reduce their risk of cardiovascular disease. A number of studies have shown the benefits of statin therapy to reduce cardiovascular disease in // various groups. It has not been clear whether type 2 diabetics who are at an increased cardiovascular risk would benefit from the drug therapy.

Researchers conducted a study to look at the effectiveness of statin therapy among type 2 diabetics.For the study, 2,800 type 2 diabetic patients in 132 centers in the United Kingdom and Ireland were randomly assigned to statin therapy or a placebo. The patients had no history of cardiovascular disease and low LDL, or bad, cholesterol levels. The patients were followed for about four years to see if they had a heart problem or stroke.

Researchers found patients on the statin therapy had a reduced risk of a heart attack by about one third compared to those on the placebo. The stroke risk was reduced by 48 percent. The study also found the statin drug, atorvastatin (Lipitor), reduced the death rate by 27 percent compared with placebo.

Study authors say statin therapy is safe and effective in reducing the risk of a cardiovascular event in patients with type 2 diabetes. However, they say the debate about whether all type 2 diabetics should receive statin treatment ought to now focus on whether any patients are at such a low risk that the treatment should be withheld.
'"/>




Page: 1

Related medicine news :

1. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
2. Eating More Often May Help Lower Cholesterol
3. Caution On Use of Cholesterol Drugs
4. High Cholesterol linked to Alzheimer’s diseas
5. Cholesterol Drug Helps After Angioplasty
6. Cholesterol lowering drugs increase neuropathy risk
7. Almonds Improve Cholesterol
8. Cholesterol-lowering therapy benefits older people also
9. Cholesterol lowering drugs aid people after heart transplant
10. New Cholesterol gene linked to Alzheimers
11. Children’s Cholesterol Matter
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... 2017 , ... Crossover Symmetry , an evidence based ... lifestyle company that provides Human Performance Training and education to tactical athletes. Together ... military officers and others in service through the development and conditioning of overall ...
(Date:4/21/2017)... ... April 21, 2017 , ... Northern California Medical ... Care Spring Symposium on April 1, 2017 in Santa Rosa. This well-attended annual ... healthcare providers an opportunity to learn about cutting edge treatments, to collaborate, share ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a ... Care of Utah (APCUT) and has appointed Rex Wheeler as its new Director of ... for our agency and our ability to provide quality care to the community,” said ...
(Date:4/21/2017)... ... , ... During April 21-23, Super-Sod will join the vendor market of the ... everyone — from the avid gardener to the landscape admirer — during the three-day ... in a grand venue, and we are certainly looking forward to participating in this ...
(Date:4/21/2017)... ... April 21, 2017 , ... National pest management association survey conducted ... of bed bug infestations over the 5-year period. In 2015 10% or US$750 million ... of bed bug infested properties. , The health and economic consequences of bed ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and ... today announced the signing of a three-year exclusive ... will deploy a dedicated sales team to introduce ... U.S., primarily focused in 13 states in the ...
Breaking Medicine Technology: